BIOMARIN PHARMACEUTICAL INC Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, conversion of convertible securities for fiscal 2014 was $21.32M, a 92.47% decline from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, conversion of convertible securities for fiscal 2013 was $283.32M, a 269727.62% increase from fiscal 2012.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, conversion of convertible securities for fiscal 2012 was $105.00K, a 99.64% decline from fiscal 2011.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, conversion of convertible securities for fiscal 2011 was $28.98M, a 75.49% decline from fiscal 2010.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2014-12-31 | $21.32M 10-K · filed 2015-03-02 | |
| 2013-12-31 | $283.32M 10-K · filed 2015-03-02 | |
| 2012-12-31 | $105.00K 10-K · filed 2015-03-02 | |
| 2011-12-31 | $28.98M 10-K · filed 2014-02-26 | |
| 2010-12-31 | $118.24M 10-K · filed 2013-02-26 | |
| 2008-12-31 | $288.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |